Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• 13th Annual Neurotech Investing & Partnering Conference in Boston, USA

• Bio€quity Europe 2018 in Ghent, Belgium

• 15th Anglonordic Life Science conference in London, UK

• Foro MEDCAP2018, Madrid, Spain

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences in May.

Click here to see the full Press Release